Research output per year
Research output per year
Personal profile
External positions
Dasman Diabetes Institute
1 Jan 1990 → …
Fingerprint
Dive into the research topics where Thamer AlEssa is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Research output
- 10 Article
-
DeFronzo, R., Abdul-Ghani, M., Baskoy, G., Nakhleh, A., Abdelgani, S., Al-Mulla, F., Abu-Farha, M., Alajmi, F., Alessa, T., & Shehadeh, N. (2024). pioglitazone amplifies the decrease in hba1c and prevents the increase in plasma ketone caused by dapagliflozin in type 1 diabetes patients. Diabetologia, 67, S60-S61.
-
Aljumah, M., Abufarha, M., Alyassen, H., Alessa, T., Devarajan, S., & Nabil, M. (2023). maternal and neonatal morbidity and mortality among covid-19 positive pregnant women with and without gdm. Diabetes Research and Clinical Practice, 197. https://doi.org/10.1016/j.diabres.2023.110416
-
Baagar, K., Alessa, T., Jayyousi, A., Ceruto, J., Alattar, A., Hamad, M., Almatrouk, H., Abdulrahman, S., Alhumaidi, H., Alandaleeb, A., Esmaeel, A., Abu-Farha, M., Al-Mulla, F., & Abdul-Ghani, M. (2023). pioglitazone for patients with type 2 diabetes admitted with covid-19 infection. Diabetologia, 66(SUPPL 1), S176-S176.